StackLeaf
← Back to feed
VERIFIEDET Stocks·positive

Biocon shares rise 2% after USFDA approval for Yesintek single-dose prefilled autoinjector

AI Summary
  • ·Biocon shares increased by 2% following the USFDA approval.
  • ·The approval is for Yesintek single-dose prefilled autoinjectors in two strengths.
  • ·This approval enhances Biocon's US immunology product offerings.
BIOCON
Read original →